PLASMAPHERESIS, CYTOXAN, SPLENECTOMY AND QUADRUPLE THERAPY TO REDUCE THE RISK OF ANTIBODY (AB) MEDIATED REJECTION IN ABO-INCOMPATIBLE LIVER-TRANSPLANTATION (ABO-I-LTX)
Dw. Hanto et al., PLASMAPHERESIS, CYTOXAN, SPLENECTOMY AND QUADRUPLE THERAPY TO REDUCE THE RISK OF ANTIBODY (AB) MEDIATED REJECTION IN ABO-INCOMPATIBLE LIVER-TRANSPLANTATION (ABO-I-LTX), Hepatology, 18(3), 1993, pp. 747-747